Novo Nordisk A/S (NVO) Stock: Revenue, Earnings, Margins & Valuation
Novo Nordisk A/S (NVO), Denmark at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report (FY 2025), visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in DKK. Free and without signup.
Novo Nordisk A/S key figures (FY 2025)
| Revenue | 309.06 DKK bn |
|---|---|
| Gross profit | 250.28 DKK bn |
| Operating income | 127.66 DKK bn |
| Net income | 102.43 DKK bn |
| Net margin | 33.1 % |
Novo Nordisk A/S revenue by segment
| Diabetes and Obesity care | 289.46 DKK bn |
|---|---|
| Rare disease | 19.61 DKK bn |
Novo Nordisk A/S business model
The income statement of Novo Nordisk A/S is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.